RANGO Registry

International, multicenter, prospective and observational registry. Evaluation of safety and efficacy of angiolite drug eluting stent in non-selected patients from the clinical daily practice.

Description

Device: angiolite

Number of patients: 654

Follow up: 6, 12 and 24- month

Type of lesion: Non-selected, real world population

Outcomes

Rango Registry results

Conclusions

Clinical events occurred in RANGO registry were very low at 12-months FU. The TLF represent a very low rate showing high efficacy, and ST of 0.61% showed a safety profile comparable with DES current in the market.

Main investigator

Dr A. Pérez de Prado, Hospital and  University of León (León, SPA)

All Clinical Trials

All Clinicals Trials
ANGIOLITE Trial
ANCHOR Trial